These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2702309)

  • 21. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
    Ewe K
    Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
    Rutgeerts P
    Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. II. Medical treatment of inflammatory bowel disease.
    Gray GM
    Calif Med; 1973 Nov; 119(5):21-4. PubMed ID: 4148269
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F; Wagner AC; Göke B
    Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on medical management of inflammatory bowel disease: ulcerative colitis.
    Hanauer SB
    Rev Gastroenterol Disord; 2001; 1(4):169-76. PubMed ID: 12120183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
    Moss AC; Cheifetz AS; Peppercorn MA
    Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):290-3. PubMed ID: 16673009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic data in inflammatory colitis].
    Karsenti P
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatal myocardial infarction in an elderly woman with severe ulcerative colitis: what is the role of steroids?
    Baty V; Blain H; Saadi L; Jeandel C; Canton Ph
    Am J Gastroenterol; 1998 Oct; 93(10):2000-1. PubMed ID: 9772083
    [No Abstract]   [Full Text] [Related]  

  • 31. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
    Fahrländer H
    Schweiz Med Wochenschr; 1987 Oct; 117(42):1620-3. PubMed ID: 3321418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proctofoam-HC for anorectal disorders.
    Med Lett Drugs Ther; 1971 Aug; 13(17):69-70. PubMed ID: 5164089
    [No Abstract]   [Full Text] [Related]  

  • 35. An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
    Khatchatourian M; Seaton TL
    Am J Gastroenterol; 1997 Sep; 92(9):1558-60. PubMed ID: 9317088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute adrenal insufficiency after stopping prolonged corticotherapy with betnesol enemas for ulcerative colitis].
    Bili H; Algayres JP; Revel F; Coutant G; Daly JP
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1113-4. PubMed ID: 10051992
    [No Abstract]   [Full Text] [Related]  

  • 38. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
    Moum B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
    Hellström PM; Schmidt D; Karlén P
    Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
    [No Abstract]   [Full Text] [Related]  

  • 40. [Budesonide and inflammatory bowel disease].
    Gomollón F; Hinojosa J; Nos P
    Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.